Aerie Pharmaceuticals, Inc. Variable Lease, Cost
Aerie Pharmaceuticals, Inc. reported Variable Lease, Cost of $1.10 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2022-02-25
- Aerie Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2019-12-31 was $200.00K.
- Aerie Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2019-09-30 was $300.00K.
- Aerie Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2019-06-30 was $500.00K.
- Aerie Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2019-03-31 was $200.00K.
- Aerie Pharmaceuticals, Inc. variable lease, cost for fiscal 2021 was $1.10M, a 57.14% increase from fiscal 2020.
- Aerie Pharmaceuticals, Inc. variable lease, cost for fiscal 2020 was $700.00K, a 46.15% decline from fiscal 2019.
- Aerie Pharmaceuticals, Inc. variable lease, cost for fiscal 2019 was $1.30M.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.10M 10-K · filed 2022-02-25 | |||
| 2020-12-31 | $700.00K 10-K · filed 2022-02-25 | |||
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $500.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.00M derived: sum of 3 quarters · filed 2022-02-25 | $1.30M 10-K · filed 2022-02-25 |
| 2019-09-30 | $300.00K 10-Q · filed 2019-11-07 | $800.00K derived: sum of 2 quarters · filed 2019-11-07 | $1.10M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $500.00K 10-Q · filed 2019-08-08 | $700.00K 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $200.00K 10-Q · filed 2019-05-08 |